Guest Editorial ASCO’s “rock concert” moments came 17 years apart—in 2005 and 2022DESTINY-04 results extend HER2-targeted therapy to a larger population in breast cancer June 10, 2022Vol.48 No.23By George W. Sledge Jr.
FreeGuest Editorial What cancer centers need to do in the wake of Buffalo, Uvalde shootings May 27, 2022Vol.48 No.21By Candace S. Johnson
FreeGuest Editorial Rob Winn on Buffalo massacre: “I grew up there. This is personal to me.” May 27, 2022Vol.48 No.21By Robert A. Winn
FreeGuest Editorial Heartbreak in South Texas: Seeing the Uvalde killings through the lens of Mays Cancer Center May 27, 2022Vol.48 No.21By Ruben A. Mesa
Cancer History ProjectFreeGuest Editorial Remembering the “Murderers’ Row” at Fox Chase’s Institute for Cancer Research May 20, 2022Vol.48 No.20By Jonathan Chernoff
Guest Editorial Let’s learn from our neighbors from the North as we get the menthol flavor out of cigarettes May 06, 2022Vol.48 No.18By David Balis
Guest Editorial National marketing and communications network advances NCI cancer centers’ mission April 22, 2022Vol.48 No.16By Erin McElwain
Guest Editorial Single-country clinical trial results: Are they applicable to other populations? March 25, 2022Vol.48 No.12By Edward S. Kim
Guest Editorial War in Ukraine: The nuclear threat increases March 25, 2022Vol.48 No.12By Robert Peter Gale
FreeGuest Editorial Collaborating to support continuing cancer care for Ukrainians March 11, 2022Vol.48 No.10By Julie R. Gralow
